ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma

Xu, Fangxing; Yan, Jinglong*; Peng, Zhibin; Liu, Jingsong; Li, Zecheng哈尔滨医科大学; 1
Frontiers in Immunology2022-12-23DOI: 10.3389/fimmu.2022.1096009
5被引7阅读
引用收藏
分享

摘要

BackgroundGlycolysis and cholesterol synthesis are crucial in cancer metabolic reprogramming. The aim of this study was to identify a glycolysis and cholesterol synthesis-related genes (GCSRGs) signature for effective prognostic assessments of osteosarcoma patients. MethodsGene expression data and clinical information were obtained from GSE21257 and TARGET-OS datasets. Consistent clustering method was used to identify the GCSRGs-related subtypes. Univariate Cox regression and LASSO Cox regression analyses were used to construct the GCSRGs signature. The ssGSEA method was used to analyze the differences in immune cells infiltration. The pRRophetic R package was utilized to assess the drug sensitivity of different groups. Western blotting, cell viability assay, scratch assay and Transwell assay were used to perform cytological validation. ResultsThrough bioinformatics analysis, patients diagnosed with osteosarcoma were classified into one of 4 subtypes (quiescent, glycolysis, cholesterol, and mixed subtypes), which differed significantly in terms of prognosis and tumor microenvironment. Weighted gene co-expression network analysis revealed that the modules strongly correlated with glycolysis and cholesterol synthesis were the midnight blue and the yellow modules, respectively. Both univariate and LASSO Cox regression analyses were conducted on screened module genes to identify 5 GCSRGs (RPS28, MCAM, EN1, TRAM2, and VEGFA) constituting a prognostic signature for osteosarcoma patients. The signature was an effective prognostic predictor, independent of clinical characteristics, as verified further via Kaplan-Meier analysis, ROC curve analysis, univariate and multivariate Cox regression analysis. Additionally, GCSRGs signature had strong correlation with drug sensitivity, immune checkpoints and immune cells infiltration. In cytological experiments, we selected TRAM2 as a representative gene to validate the validity of GCSRGs signature, which found that TRAM2 promoted the progression of osteosarcoma cells. Finally, at the pan-cancer level, TRAM2 had been correlated with overall survival, progression free survival, disease specific survival, tumor mutational burden, microsatellite instability, immune checkpoints and immune cells infiltration. ConclusionTherefore, we constructed a GCSRGs signature that efficiently predicted osteosarcoma patient prognosis and guided therapy.

学科与关键词

关键词
glycolysischolesterolosteosarcomaprognosissignatureimmuneTRAM2
相关
加载中…
  • Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
    Zhong, Yujian; Zhang, Yubiao; Wei, Sixing; Chen, Junwen; Zhong, Changheng; Cai, Wenxiang; Jin, Wenyi*; Peng, Hao*Frontiers in Endocrinology, 2022, 13: 1030655.被引 12
  • The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma
    Su, Zexin; Wang, Chenyang; Pan, Runsang; Li, Hongbo; Chen, Junkai; Tan, Jianye; Tian, Xiaobin*; Lin, Tiao*; Shen, Jingnan*Frontiers in Immunology, 2022, 13: 1028263.被引 4
  • Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma
    Huang, Liangkun; Sun, Fei; Liu, Zilin; Jin, Wenyi; Zhang, Yubiao; Chen, Junwen; Zhong, Changheng; Liang, Wanting; Peng, Hao*Cancers, 2023, 15(8): 2405.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-12-23
卷期
第 13 卷
页码
1096009
DOI
10.3389/fimmu.2022.1096009
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [82072472]

作者

  • X

    Xu, Fangxing (第一作者)

    2 · harbin med univ

  • Y

    Yan, Jinglong (通讯)

    2 · harbin med univ

查看全部 5 位作者收起作者
  • P

    Peng, Zhibin

    1 · harbin med univ

  • L

    Liu, Jingsong

    1 · harbin med univ

  • L

    Li, Zecheng

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417